Abstract Number: 2080 • 2012 ACR/ARHP Annual Meeting
IL-20 Is Not Involved in Mouse Collagen Induced Arthritis
Background/Purpose: Interleukin-20 (IL-20) is a pro-inflammatory cytokine involved in the pathogenesis of rheumatoid arthritis (RA). Clinical phase 2a testing has shown that treatment with an…Abstract Number: 2041 • 2012 ACR/ARHP Annual Meeting
Improving Access and Patient Education in Rheumatology: the Gout Shared Medical Appointment; a Quality Improvement Initiative
Background/Purpose: Patients experience long waits for consultations in Rheumatology at Dartmouth-Hitchcock Medical Center (DHMC). The cause of this is multi-factorial, including provider referral patterns, patient preferences,…Abstract Number: 2042 • 2012 ACR/ARHP Annual Meeting
Enhancing Shared Decision-Making in Juvenile Idiopathic Arthritis
Background/Purpose: Juvenile idiopathic arthritis (JIA) is a chronic disease that requires long-term treatment. Patients and families face multiple treatment decisions over the course of illness…Abstract Number: 2043 • 2012 ACR/ARHP Annual Meeting
Documentation of Improvement Over 2 Months in Osteoarthritis, Systemic Lupus Erythematosus, Spondyloarthropathy and Gout Similarly to Rheumatoid Arthritis According to Function, Pain, Patient Global Estimate and RAPID3 On a Multidimensional Health Assessment Questionnaire (MDHAQ)
Background/Purpose: The health assessment questionnaire (HAQ) and multidimensional HAQ (MDHAQ) were developed initially to assess patients with rheumatoid arthritis (RA). The most feasible method to…Abstract Number: 2044 • 2012 ACR/ARHP Annual Meeting
Trying to Improve Care: A Review of the Morbidity and Mortality Conference in the Division of Rheumotology
Background/Purpose: The morbidity and mortality conference (M&MC) is one of academic medicine’s most visible fora for discussion of adverse events and errors; however it is…Abstract Number: 2045 • 2012 ACR/ARHP Annual Meeting
Treatment Patterns and Monitoring of Serum Uric Acid Levels in a Large Cohort of Gout Patients in the United States: Is There Room for Improvement?
Background/Purpose: Currently, there are no guidelines in the United States on monitoring serum uric acid (sUA) levels in gout and gout treatment patterns. However, there…Abstract Number: 2046 • 2012 ACR/ARHP Annual Meeting
Matching of Patients’ Actual and Desired Roles in Treatment Decision Making and Trust in Physicians
Background/Purpose: Shared decision-making (SDM), in which the physician and patient work together through all phases of the decision-making process, has been of increasing significance. But…Abstract Number: 2047 • 2012 ACR/ARHP Annual Meeting
Impact of a Rheumatology Consultation Service in Hospitalized Patients
Background/Purpose: Rheumatologists provide hospital in-patient consultation for urgent and emergency referrals. In an increasingly cost-conscious, accountable, and integrated health-care system, the appropriate role of specialty…Abstract Number: 2048 • 2012 ACR/ARHP Annual Meeting
Four Physician Global Assessments for Overall Status, Inflammation, Damage, and Unexplained Symptoms Are Useful in Usual Care of Patients with Osteoarthritis, Fibromyalgia, Systemic Lupus Erythematosus, and Spondyloarthropathy, As Well As Rheumatoid Arthritis
Background/Purpose: A physician global estimate (DOCGL) is important in clinical decisions concerning patients with rheumatoid arthritis (RA), and often is the most efficient of the…Abstract Number: 2049 • 2012 ACR/ARHP Annual Meeting
Improving Pneumococcal Vaccination and Documentation for Immunosuppressed Patients At a University-Based Rheumatology Clinic
Background/Purpose: Centers for Disease Control and Prevention Guidelines recommend that all immunosuppressed patients receive the pneumococcal vaccine. The American College of Rheumatology Task Force Panel…Abstract Number: 2050 • 2012 ACR/ARHP Annual Meeting
Are Patients Meeting the Updated Physical Activity Guidelines? Physical Activity Participation, Recommendation, and Preferences Among Adults with Rheumatic Diseases
Background/Purpose: Physical activity (PA) reduces disability, comorbidity, and risk of premature mortality in people with rheumatic diseases, and clinical guidelines recommend that PA should be…Abstract Number: 2051 • 2012 ACR/ARHP Annual Meeting
Standardized Data Collection Supports Reliable Reporting of Rheumatoid Arthritis (RA) Measures for the Medicare Physicians’ Quality Reporting System
Background/Purpose: The Medicare Physicians' Quality Reporting System (PQRS) program encourages physicians to measure and report clinical processes and disease outcomes that correlate with quality care,…Abstract Number: 2052 • 2012 ACR/ARHP Annual Meeting
Effect of Community Characteristics On Quality of Care in Systemic Lupus Erythematosus
Background/Purpose: In prior studies we established that living in communities of concentrated poverty was associated with fewer physician visits and select SLE outcomes after taking…Abstract Number: 2053 • 2012 ACR/ARHP Annual Meeting
Tele-Rheumatology: The Future Is Now
Background/Purpose: Access to rheumatologic consultation is limited by available expertise due to inadequate manpower and maldistribution of resources. Rural New England is particularly challenging because…Abstract Number: 2054 • 2012 ACR/ARHP Annual Meeting
Safety of Joint and Soft Tissue Injections in Patients On Warfarin Anti-Coagulation
Background/Purpose: Joint and soft tissue injections are commonly performed in clinical practice. An increasing number of patients are prescribed warfarin. Joint and soft tissue injections…